Clinico-biochemical profile and etiology of acute viral hepatitis in hospitalized children: A study from Eastern India by Behera, Manas Ranjan & Patnaik, Lipilekha
Vol 3 | Issue 4 | Oct - Dec 2016 Indian J Child Health 317
Original Article
Clinico-biochemical profile and etiology of acute viral hepatitis in hospitalized 
children: A study from Eastern India
Manas Ranjan Behera, Lipilekha Patnaik
From 1Department of Pediatrics, Kalinga Institute of Medical Sciences, 2Department of Community Medicine, Institute of Medical Sciences & Sum 
Hospital, Bhubaneswar, Odisha, India
Correspondence to: Dr. Manas Ranjan Behera, QR No. D/15, Staff QR, KIMS Campus, KIIT University, Bhubaneswar - 751 024, 
Odisha, India. Phone: +91-9937022115. E-mail: drmanas73@yahoo.co.in
Received – 28 September 2016 Initial Review – 07 October 2016 Published Online – 26 October 2016
Acute viral hepatitis (AVH) is a primary disease of liver with systemic involvement, mainly caused by five hepatotropic viruses; namely A, B, C, D, and E. It is 
still a major public health problem of developing countries 
such as India, despite improving socioeconomic condition, 
sanitation, and health awareness [1]. The clinical spectrum of 
AVH ranges from entirely subclinical and inapparent infection to 
rapidly progressing and fulminant hepatic failure [2]. Hepatitis 
A (HAV) and E (HEV) viruses are feco-orally transmitted 
and self-limiting, whereas hepatitis B (HBV), C (HCV) and 
D (HDV) are transmitted parenterally and may progress to 
chronic hepatitis.
India is hyper-endemic for hepatitis A and E [3]. HAV is 
the most common cause of AVH in children, whereas HEV is 
predominant in adults [4]. Because of the improvement in living 
standard, the pattern of AVH due to HAV is changing from an 
asymptomatic or mild infection to an increased incidence of 
symptomatic or severe disease [5]. HAV is also the most common 
cause of fulminant hepatitis in children in India and worldwide [6].
HEV has been associated with the large scale of epidemics and 
outbreaks in various parts of India. It is related to high attack rate 
and mortality in pregnant women [7]. Though it is a major disease 
of adults, it can affect children with a similar picture of hepatitis. 
It is an unlikely cause of fulminant hepatitis in children [8].
In India, HBV infection is of intermediate endemicity, with 
nearly 4% of the population being chronic carriers [9]. The most 
cases of acute hepatitis due to HBV are subclinical and less 
than 1% of symptomatic diseases are fulminant. Young children 
rarely develop acute clinical disease, but many of those infected 
before the age of seven become chronic carriers [7]. HCV is an 
infrequent cause of acute icteric hepatitis [10], but causes most of 
post-transfusion hepatitis [11]. HDV infection is found in fewer 
than 10% of patients with acute or chronic HBV infection [12].
Owing to paucity of data on the incidence and etiology of 
AVH in Indian children, this study was undertaken. The objective 
of the study was to identify the etiology, and to assess the clinical 
and biochemical profile, complications and outcome of AVH in 
children.
ABSTRACT
Background: Acute viral hepatitis (AVH) in children continues to be a major public health problem in India. Objective: To identify 
the etiology, and to assess the clinical and biochemical profile, complications and outcome of AVH in children. Materials and 
Methods: A total of 76 children with the clinical diagnosis of AVH were included in this record based retrospective study from 
January 2014 to August 2016. Data on clinical characteristics, laboratory parameters, immediate outcome, and treatment received 
were obtained, and analysis was performed. Results: Specific etiological agents were identified in 84.2% children. Out of these, 
93.7% were due to a single virus, whereas 6.3% were due to mixed infection. Hepatitis A virus (HAV) was found to be the sole 
infecting agent in 75% children. Hepatitis B virus (HBV) and hepatitis E virus (HEV) were found in 12.5% and 6.2% children, 
respectively. Mixed infection was seen in the form of HAV and HEV in 3.1%, and HAV and HBV in 3.1%. The mean age of children 
with hepatitis A was 8.29±2.74 years, with 70.8% boys and 29.2% girls. Common clinical features were jaundice (95.8%), loss 
of appetite (95.8%), tender hepatomegaly (68.8%), fever (50%), vomiting (50%), pain abdomen (33.3%), splenomegaly (31.2%), 
itching (27.1%), bleeding (2.1%), and seizure (2.1%). Acute liver failure was seen in 4.1% and 2% of admitted children died. The 
mean age of presentation of AVH due to HBV and HEV were 10.7±2.6 years and 10±2.2 years, respectively. Clinical features were 
similar without any complications or mortality. Significant elevations in hepatic enzymes were seen in mixed infection due to HAV 
and HEV (p<0.05). Conclusion: HAV is the primary cause of morbidity and mortality due to AVH in this region. HBV and HEV 
infection may present with similar clinical features, and serological testing must be done to identify the cause.
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MATERIALS AND METHODS
This was a retrospective record based study conducted at a tertiary 
care teaching hospital of Eastern India. The data from January 
2014 to August 2016 were analyzed in a period of 1-month. All 
the case records of children up to 15 years of age admitted to 
the hospital with a diagnosis of “AVH” or “viral hepatitis” or 
“hepatitis” were retrieved from the medical records department. 
All the children with acute onset of jaundice suggestive of acute 
hepatitis or having elevated serum transaminase level more than 
2 times normal and with at least one positive serological viral 
marker (immunoglobulin M [IgM] HAV, IgM HEV, hepatitis B 
surface antigen [HBsAg], and anti-HCV) were included in the 
study. Children <1 year of age, having chronic liver disease or 
metabolic disease, biliary obstruction and records with incomplete 
data were excluded from the study. HBsAg positive but IgM-anti 
HBc negative children and anti-HCV positive, but HCV RNA 
negative children were also excluded from the study.
Acute hepatitis was defined as acute illness with discrete 
onset of symptoms (e.g., nausea, anorexia, fever, malaise, or 
abdominal pain) with rise of total serum bilirubin (≥2 mg/dl) 
or elevation of serum alanine aminotransferase (ALT; ≥twice 
the upper limit of normal) at any point in the course of the 
disease in the absence of underlying chronic liver disease [13]. 
Fulminant hepatitis or acute liver failure (ALF) was defined 
as the presence of biochemical evidence of acute liver injury 
(<8 weeks duration); no evidence of chronic liver disease; and 
hepatic based coagulopathy defined as a prothrombin time (PT) 
>15 s or international normalized ratio (INR) >1.5 not corrected 
by vitamin K in the presence of clinical hepatic encephalopathy, 
or a PT>20 sec or INR >2 regardless of the presence of clinical 
hepatic encephalopathy [14].
AVH A was diagnosed by the presence of Anti-HAV IgM in 
the serum. Titer estimation was performed by fully automated 
bidirectionally interfaced chemiluminescent immunoassay 
method using HAV Ab-IgM Reagent kit. Values ≥1.2 were 
considered as positive. Diagnosis of acute hepatitis B was based 
on the presence of IgM antibody against hepatitis B core antigen 
(IgM anti-HBc) with or without HBsAg. Acute hepatitis E and 
hepatitis C were diagnosed by the presence of IgM antibody against 
HEV (anti-HEV IgM) and anti- HCV antibody, respectively.
Statistical analysis was performed using SPSS software 
version 20. Univariate and bivariate frequency tables were 
generated based on categorical data. Association between 
parameters was studied using chi-square test at appropriate level 
of significance. Association was considered to be statistically 
significant at p<0.05.
RESULTS
A total of 76 cases with clinical diagnosis of AVH were admitted 
during the study period of 3-year. 12 cases were excluded as 
per the criteria (no serological marker in 8 cases, only HBsAg 
positive in 2 cases and incomplete records in 2 cases). So for the 
final analysis 64 case records were considered.
In this study, we found hepatitis A in 48 (75%), hepatitis B in 
8 (12.5%) and hepatitis E in 4 (6.25%) children. Mixed infection 
was seen in 4 (6.25%) cases. Two (3.1%) had concurrent infection 
with hepatitis A and E, whereas the other two (3.1%) had hepatitis 
A and B. Age distribution of children with AVH is depicted in 
Table 1.
AVH due to HAV was seen to be more common in boys 
(70.8%) as compared to girls (29.2%). Age of the patients ranged 
from 4 to 14 years. Mean age of presentation was 8.29±2.74 years. 
Maximum number of cases (20.8%) was admitted in the month of 
August (Fig. 1). The most common symptoms at presentation were 
jaundice and loss of appetite (95.8%). Other symptoms were fever 
(50%), vomiting (50%), pain abdomen (33.3%), itching (27.1%), 
bleeding from mucosal site (2.1%), and seizure (2.1%). Tender 
hepatomegaly was seen in 68.8% cases, whereas splenomegaly 
was seen in 31.2% cases. Interloop ascites and pleural effusion on 
ultrasonography were seen in 10.4 % and 4.2% cases, respectively. 
The mean duration of hospital stay was 7.42±3.1 days. 47 (98%) 
children had serum bilirubin levels <10 mg/dl. Serum aspartate 
aminotransferase (AST) and ALT levels were significantly high 
(>1,000 U/L) in 6 (12.5%) and 10 (20.8%) children, respectively. 
ALF was seen in 2 (4.1%) children and one of them (2%) died.
AVH due to HBV and HEV as the sole cause were more 
commonly seen in boys (75%). The mean ages of presentation 
were 10.7 ± 2.6 years (range 7-15 years) and 10 ± 2.2 years (range 
7-12 years), respectively. The symptoms and signs are illustrated 
in Table 2. All of them had clinical jaundice at admission. There 
were no complications or mortality due to HBV and HEV. Tables 3 
and 4 show the hematological and biochemical parameters as 
observed in the three groups of viral hepatitis. We did not find 
any child affected with HCV or HDV.
Figure 1: Month wise distribution of children with hepatitis A
Table 1: Age distribution of children with AVH
Age (years) Hepatitis
A (48) B (8) E (4) A+E (2) A+B (2)
<5 6 0 0 0 0
5-10 30 3 2 2 1
>10 12 5 2 0 1
AVH: Acute viral hepatitis 
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Mixed infection due to HAV+HEV and HAV+HBV were 
found in two cases (3.1%) each. Total serum bilirubin, AST, ALT, 
alkaline phosphatase and GGT (Gamma-glutamyl transpeptidase) 
values in the first group were 15.2, 1404.5, 1456, 336.7 and 
90.17, respectively; whereas in the second group the values 
observed were 6.35, 206, 306, 467.5 and 56, respectively. All the 
biochemical parameters were significantly raised in the children 
affected with HAV and HEV coinfection (p<0.05).
DISCUSSION
We retrospectively studied 64 cases clinically diagnosed as AVH. 
The most common cause was found out to be HAV. Boys were more 
commonly affected than girls (M: F=44:20) in both enterically 
and parenterally transmitted infections. Similar findings were 
reported by other studies from India and outside [15-17].
Maximum number of children (62.5%) affected by hepatitis 
A were in the age group of 5-10 years. In this study, we found 
adolescents (10-15 years) were affected with HAV in 25% cases. 
A similar study from Chennai by Kamath et al. showed 61.6% and 
15.9% of subjects were in the age group of 5-10 and 10-15 years, 
respectively [18]. The older age group involvement could be due 
to the shifting of epidemiological pattern of HAV infection. With 
the improving sanitary conditions, there is a recent decline in the 
anti-HAV antibody prevalence among school children, which 
predisposes older children to acquire the disease, occurrence of 
outbreaks and severe manifestation with ALF [19].
Although HAV infection was seen round the year in this study, 
maximum number of cases was admitted during the rainy season 
(July, August, and September). Jaundice, loss of appetite, vomiting, 
and fever were the common presenting symptoms. Atypical 
features such as splenomegaly, ascites, pleural effusion, and ALF 
were seen in 31.2%, 10.4%, 4.2%, and 4.2% children, respectively. 
Although very high serum AST and ALT levels (>1000 IU/L) were 
seen in 16 cases, serum bilirubin level more than 10 mg/dl was 
found in only one case (2.1%). Serum alkaline phosphatase levels 
were found to be increased in 52.1% cases, whereas raised serum 
Gamma-Glutamyl transpeptidase (GGT) levels were seen in 97.9% 
cases, which is a more specific indicator of cholestasis. Although 
hypoalbuminemia and coagulopathy (PT >15 s) were seen in 14.6% 
and 12.5% cases, respectively, ALF occurred in 4.1% with mortality 
in 2%. Rest of them recovered with conservative management. The 
deceased had very high total serum bilirubin levels (40.7 mg/dl), 
but moderate increase in transaminase levels (AST: 371 IU/L, ALT: 
576 IU/L, ALK P: 237.7 IU/L).




Jaundice 46 (95.8) 8 (100) 4 (100)
Loss of apetite 46 (95.8) 8 (100) 4 (100)
Fever 24 (50) 5 (62.5) 4 (100)
Vomiting 24 (50) 3 (37.5) 3 (75)
Pain abdomen 16 (33.3) 3 (37.5) 2 (50)
Bleeding 1 (2.1) 0 0
Seizure 1 (2.1) 0 0
Hepatomegaly 33 (68.8) 5 (62.5) 4 (100)
Splenomegaly 15 (31.2) 2 (25) 0
Itching 13 (27.1) 5 (62.5) 1 (25)
Ascitis 5 (10.4) 0 1 (25)
Pleural effusion 2 (4.2) 0 0
AVH: Acute viral hepatitis
Table 3: Hematological parameters in children with AVH
Parameters Hepatitis
A B E
Hb (g%) 10.78±1.6 11.11±1.4 12.84±1.03
TLC (×103/cmm) 8.01±2.4 9.07±1.7 7.57±1.2
PCV (%) 34.75±5.2 36.83±4.7 39.78±3.1
MCV (fl) 76.09±10.7 76.69±6.6 88.43±5.7
MCH (pg) 23.44±3.8 23.63±2.0 28.56±1.8
MCHC (%) 30.72±1.09 30.79±1.1 32.3±0.3
Platlet (×104/cmm) 282.38±103.3 309.0±82.7 157.86±135.8
AVH: Acute viral hepatitis, Hb: Hemoglobin, TLC: Total leukocyte count, 
PCV: Packed cell volume, MCV: Mean corpuscular volume, MCH: Mean corpuscular 
hemoglobin, MCHC: Mean corpuscular hemoglobin concentration
Table 4: Biochemical parameters in children with AVH at 
presentation
Parameters HEP
A (n=48) B (n=8) E (n=4)
Total serum bilirubin (mg/dl)
Normal 1 (2.1) 0 0
<5 29 (60.4) 1 (12.5) 4 (100)
5-10 17 (35.4) 5 (62.5) 0
>10 1 (2.1) 2 (25) 0
AST (u/l)
Normal 2 (4.2) 0 0
<500 34 (70.8) 2 (25) 0
500-1000 6 (12.5) 3 (37.5) 1 (25)
>1000 6 (12.5) 3 (37.5) 3 (75)
ALT (u/l)
Normal 1 (2.1) 0 0
<500 26 (54.1) 1 (12.5) 0
500-1000 11 (22.9) 6 (75) 0
>1000 10 (20.8) 1 (12.5) 4 (100)
Elevated ALK P (u/l) 25 (52.1) 8 (100) 4 (100)
Elevated GGT (u/l) 47 (97.9) 8 (100) 4 (100)
Serup protein (<6 gm/dl) 2 (4.2) 0 0
S. Albumin (<3.5 gm/dl) 7 (14.6) 2 (25) 0
S. Globulin (<2 gm/dl) 1 (2.1) 0 0
PT (> 15 s) 6 (12.5) 5 (62.5) 0
INR (>1.5) 2 (4.2) 2 (25) 0
Prolonged PT, INR 2 (4.2) 2 (25) 0
Normal values for total serum bilirubin≤1 mg/dl, AST: ≤40 U/L, ALT: ≤40 U/L, 
ALP: 1-9 years: 145-420, 10-11 years: 130-560, 12-13 years (M): 200-495, (F):105-420 
U/L, GGT. AST: Asprtatate aminotransferase, ALT: Alanine aminotransferase, 
ALP: Alkaline phosphatase, GGT: Gamma glutamyl transpeptidase, PT: Prothromin 
time, INR: International normalized ratio, AVH: Acute viral hepatitis
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In the current study, HEV was found to be the single cause 
of AVH in 6.25% cases. 50% were of age group 10-15 years 
with male predominance (75%) and maximum cases (50%) 
occurred in the rainy season. Clinical feature was almost similar 
to HAV group. Although very high serum levels of AST and ALT 
(AST: 2288±1203.1, ALT: 2653±1344.4) were seen, there was no 
complication and recovery was uneventful.
Interestingly, we found HBV to be the second most common 
cause of AVH in contrast to other studies [15-17]. This can be 
contributed to the following factors. First, many of the children 
were of poor socioeconomic status and from tribal communities. 
Poor coverage of vaccination program, high endemicity in 
certain groups, limited knowledge of preventing programs and 
lack of education may have contributed to it. Some studies have 
shown very high HBsAg positivity among tribal population 
of India [20]. Second, HEV infection in children is mostly 
asymptomatic or mild. Hence, they most probably did not 
need hospitalization. Male predominance, similar presenting 
symptoms as the other two groups, good recovery without any 
complications were the characteristic features. However, these 
patients need regular follow-up for the development of chronic 
hepatitis or carrier state.
Mixed infections were also seen in this study in the form 
of HAV+HEV and HAV+HBV; 2 case each. All the four cases 
recovered without any complications. Arora et al. in their study 
found mixed infection with HAV and HEV to be the most 
common cause of ALF in children (60%) [21]. Although some 
study say dual infection with HEV and other hepatotropic viruses 
to be associated with greater elevation of AST and ALT [22], 
similar conclusions could not be drawn from the present study 
due to small sample size.
One of the merits of the study is that very few studies had been 
reported from Eastern India regarding AVH in children. It has got 
limitations too. It was conducted in a tertiary care hospital among 
hospitalized children. Hence, the clinical profile may not be 
generalized to the community. Second, as this was a retrospective 
study, proper follow-up was not possible and the long-term 
outcome could not be studied. Further larger community-based 
studies are needed to know the sero-epidemiolgy of viral hepatitis 
in this part of the country.
CONCLUSION
AVH is a major public health problem in India. HAV, HBV, 
and HEV are prevalent and can cause sporadic or epidemic 
AVH. Although clinical features are similar, death and atypical 
presentations are more common in hepatitis A infection. Better 
sanitation, provision of clean drinking water, proper sewage 
disposal, and public education are the mainstays for prevention of 
HAV and HEV infection. Universal vaccination against HAV and 
HBV should be the focus of authorities to prevent morbidity and 
mortality due to these common pathogens.
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